Adaptimmune
Edit

Adaptimmune

http://www.adaptimmune.com/
Last activity: 09.03.2024
Categories: BioTechDevelopmentITLearnMedtechOwnProduct
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
Mentions
50
Location: United Kingdom, England, Abingdon
Total raised: $104M

Investors 8

Funding Rounds 1

DateSeriesAmountInvestors
25.09.2014-$104M-

Mentions in press and media 50

DateTitleDescriptionSource
23.12.2022Adaptimmune Announces Initiation of Biologics License Applic...- Afami-cel has the potential to be the first approved engineered TCR T-cell therapy for a solid tum...einpresswi...
04.10.2022ROTH Capital Partners to Host Inaugural Healthcare Opportuni...Event to feature company presentations and one-on-one meetings between institutional investors and s...einpresswi...
15.09.2022Sarcoma Foundation of America Honors Adaptimmune Therapeutic...Adaptimmune Therapeutics has been selected to receive the 2022 Vision of Hope Award during SFA’s Sta...einpresswi...
15.11.2021Here’s Why Roche Stock May Continue To Trend HigherLogo on building exterior at the Silicon Valley headquarters of pharmaceutical company Roche, Santa ...forbes.com...
08.09.2021Covid-19 roundup: Gates Foun­da­tion, Ex­sci­en­tia team up ...UK-based AI dis­cov­ery out­fit Ex­sci­en­tia has signed its name to a $70 mil­lion col­lab­o­ra­tio...endpts.com...
08.09.2021Mer­ck KGaA en­trusts se­cre­tive start­up with a mid-stage ...A se­cre­tive French biotech has im­port­ed a drug from Ger­many’s Mer­ck KGaA that will leapfrog th...endpts.com...
08.09.2021As blue­bird plans its big split, rare dis­ease head An­drew...As Nick Leschly counts down his fi­nal month as chief blue­bird — be­fore tak­ing on the new role of...endpts.com...
08.09.2021A few months in­to his new role at At­tralus, ex-Pur­due chi...Cancer player MacroGenics scored a big win with its full approval for anti-HER2 drug Margenza last w...endpts.com...
08.09.2021Look­ing for fresh start fol­low­ing a Duchenne dis­as­ter, ...The lead­ers of Cataba­sis Phar­ma­ceu­ti­cals have de­creed that the biotech’s name is no more. Cat...endpts.com...
08.09.2021A few months in­to his new role at At­tralus, ex-Pur­due chi...Months af­ter Bay Area start­up At­tralus tapped Mark Tim­ney to its helm, the ex-Pur­due Phar­ma ch...endpts.com...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In